High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$22K
$22,935
Total Sells (Filtered)
$3.6M
$3,587,957
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Discretionary Buy
|
2026-02-06 | $810 | P | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Discretionary Buy
|
2025-12-23 | $2,611 | P | Form 4 |
|
GALT
P
GALECTIN THERAPEUTICS INC
FREEMAN KEVIN D
• Director
Discretionary BuyΔOwn +11.1%
2025-12-23
$19,514
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Discretionary BuyΔOwn +11.1%
|
2025-12-23 | $19,514 | P | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Equity Compensation
2025-12-17
$35,469x4
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-17 | $35,469x4 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-17
$136,872x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-17 | $136,872x3 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Equity Compensation
|
2025-12-17 | $22,391x2 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-12-17 | $55,241 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
Equity Compensation
2025-12-17
$39,600x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-17 | $39,600x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -42.0%
2025-12-17
$172,424x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -42.0%
|
2025-12-17 | $172,424x2 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-12-16 | $204,335 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
Equity Compensation
2025-12-15
$35,015x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-15 | $35,015x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -42.9%
2025-12-15
$53,027
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -42.9%
|
2025-12-15 | $53,027 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
Equity Compensation
2025-12-12
$82,339x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-12 | $82,339x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -63.9%
2025-12-12
$124,181
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -63.9%
|
2025-12-12 | $124,181 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-12-03 | $687,600 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-12-02 | $164,100 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-18 | $75,851x2 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
CALLICUTT JACK W
• CFO
10b5-1 SellΔOwn -70.5%
2025-11-18
$288,187x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -70.5%
|
2025-11-18 | $288,187x2 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-18 | $16,211 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-18 | $41,723 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-17 | $43,706x3 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
CALLICUTT JACK W
• CFO
10b5-1 SellΔOwn -23.4%
2025-11-17
$190,662x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -23.4%
|
2025-11-17 | $190,662x3 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-17 | $37,475 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-17 | $94,643 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-11-13
$215,038x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-11-13 | $215,038x3 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -78.4%
2025-11-13
$435,505x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -78.4%
|
2025-11-13 | $435,505x3 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-11-11 | $210,000 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-10 | $7,717x3 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -18.0%
|
2025-11-10 | $31,884x3 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-10 | $4,462 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-10 | $11,252 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-05 | $962x3 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 Sell
|
2025-11-05 | $1,200 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-05 | $478 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-05 | $1,200 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-04 | $46,085x3 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
CALLICUTT JACK W
• CFO
10b5-1 SellΔOwn -53.9%
2025-11-04
$173,778x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -53.9%
|
2025-11-04 | $173,778x3 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-04 | $34,464 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-04 | $87,529 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-03 | $6,123x3 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -14.1%
|
2025-11-03 | $22,898x3 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-03 | $3,107 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-03 | $7,813 | S | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
10X Fund, L.P.
• 10% Owner
Discretionary Sell
2025-10-22
$246,800x2
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-10-22 | $246,800x2 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-09-12 | $11,927 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -53.4%
|
2025-09-12 | $56,054 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-09-12 | $33,460 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-09-12 | $89,048 | S | Form 4 |